Pretty proteomic pictures

Bioinformatics solutions provider Ludesi AB

Register for free to listen to this article
Listen with Speechify
0:00
5:00
LUND, Sweden—Bioinformatics solutions provider Ludesi AB announced recently that Baltimore's Johns Hopkins Bayview Proteomics Center had chosen its 2-D gel image analysis system for its efforts to develop methods to investigate biological processes involved in human diseases. The agreement provides Ludesi with another high-profile entry into a 2-D gel market that is projected to surpass $700 million by 2010 according to a report by Frost & Sullivan.
 
"Johns Hopkins Bayview Proteomics Center and Johns Hopkins School of Medicine is world-renowned for scientific excellence and front-end applied medical research," said Ola Forsstrom-Olsson, Ludesi CEO. "It is an honor to work with such successful and skilled scientists."
 
Although technical advances have pushed throughput for a variety of protein separation techniques, stalwart 2-D electrophoresis remains a major player in the proteomics marketplace. In part, this has been due to advances in gel imaging technologies that allow sample processing and data analysis to be largely automated.


Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

September 2024 front cover

Latest Issue  

• Volume 20 • Issue 5 • September 2024

September 2024

September 2024 Issue